XML 104 R67.htm IDEA: XBRL DOCUMENT
v3.21.2

Fair value measurements - Additional information (Details) $ in Thousands |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | ---
Feb. 16, 2021 USD ($) | Feb. 28, 2021 USD ($) Plan shares | Feb. 10, 2021 USD ($) Plan | Jun. 30, 2020 USD ($) shares | Jul. 03, 2021 USD ($) Business shares | Jun. 27, 2020 USD ($) | Jul. 03, 2021 USD ($) Business shares | Jul. 03, 2021 USD ($) Business shares | Jun. 27, 2020 USD ($) | Jun. 27, 2020 USD ($) | Dec. 31, 2018 USD ($) | Feb. 15, 2021 | Dec. 31, 2020 USD ($) Plan shares | Dec. 31, 2019 USD ($) shares
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of contingent consideration |  |  |  |  | $ 641 | $ 0 | $ 641 | $ 641 | $ 0 | $ 0 |  |  |  |
Number of equity-based compensation plans |  |  | 2 |  | 2 |  | 2 | 2 |  |  |  |  |  |
Cash paid to settle award |  |  | $ 479 |  |  |  |  |  |  |  |  |  |  |
Number of shares issued (in shares) | shares |  |  |  |  |  |  |  | 24,063 |  |  |  |  |  |
EPR unit, entitled percentage of distributions |  |  |  |  |  |  |  |  |  |  |  | 0.55% |  |
Accrued equity-based compensation |  |  |  |  | $ 10,875 |  | $ 10,875 | $ 10,875 |  |  |  |  | $ 11,054 |
Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity-based compensation plans | Plan |  | 2 |  |  |  |  |  |  |  |  |  |  |  |
Cash paid to settle award |  | $ 10,875 |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued (in shares) | shares |  | 798,422 |  |  |  |  |  |  |  |  |  |  |  |
Bio Ventus LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of contingent consideration |  |  |  |  |  |  |  |  |  |  | $ (739) |  |  |
Number of equity-based compensation plans | Plan |  |  | 2 |  |  |  |  |  |  |  |  |  | 2 |
EPR unit, entitled percentage of distributions |  |  |  |  |  |  |  |  |  |  |  | 0.55% |  |
Accrued equity-based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 11,054 | $ 15,547
Equity Participation Right Unit [Member] | Bio Ventus LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity participation right estimated accrued preferred distribution |  |  |  |  |  |  |  |  |  |  |  |  | 43,854 |
Bioness, Inc |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value of contingent consideration |  |  |  |  | $ 641 |  |  |  |  |  |  |  |  |
Management Incentive Plan And Liability-Classified Awards |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of awards outstanding (in shares) | shares |  |  |  |  | 183,078 |  | 183,078 | 183,078 |  |  |  |  |  |
Cash paid to settle award |  |  |  |  |  |  | $ 10,802 |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  | 12 months |  |  |  |  |  |  |
Management Incentive Plan And Liability-Classified Awards | Bio Ventus LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of awards outstanding (in shares) | shares |  |  |  | 150,252 |  |  |  |  |  |  |  |  |  |
Cash paid to settle award |  |  |  | $ 6,329 |  |  |  |  |  |  |  |  |  |
Accrued equity-based compensation |  |  |  |  |  |  |  |  |  |  |  |  | $ 11,054 |
Number of equity instruments other than options outstanding, including both vested and non-vested instruments | shares |  |  |  | 333,330 |  |  |  |  |  |  |  |  | 183,078 | 333,330
Accrued equity-based compensation, less current portion |  |  |  |  |  |  |  |  |  |  |  |  | $ 29,249 |
Management Incentive Plan And Liability-Classified Awards | Bio Ventus LLC [Member] | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of awards outstanding (in shares) | shares |  | 183,078 |  |  |  |  |  |  |  |  |  |  |  |
Cash paid to settle award |  | $ 10,802 |  |  |  |  |  |  |  |  |  |  |  |
Equity Participation Right Unit [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid to settle award | $ 3,327 |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Participation Right Unit [Member] | Bio Ventus LLC [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
EPR unit, entitled percentage of distributions |  |  |  |  |  |  |  |  |  |  |  |  | 0.55% |
Equity Participation Right Unit [Member] | Bio Ventus LLC [Member] | Subsequent Event [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid to settle award |  | $ 3,327 |  |  |  |  |  |  |  |  |  |  |  |
BV LLC Employees Terminated Prior To IPO | Management Incentive Plan And Liability-Classified Awards |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash paid to settle award |  |  |  |  |  |  | $ 10,875 |  |  |  |  |  |  |
BV LLC Employees Active At IPO | Management Incentive Plan And Liability-Classified Awards | Common Class A |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued (in shares) | shares |  |  |  |  |  |  | 798,422 |  |  |  |  |  |  |

X
- Definition Equity Participation Right, Entitled Percentage Of Distributions + References No definition available. + Details
Name: | bvs_EquityParticipationRightEntitledPercentageOfDistributions
Namespace Prefix: | bvs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number Of Equity-Based Compensation Plans + References No definition available. + Details
Name: | bvs_NumberOfEquityBasedCompensationPlans
Namespace Prefix: | bvs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of cash eligible for distribution to members or limited partners of limited liability company (LLC) or limited partnership (LP), subject to reserves to be maintained as defined in operating or partnership agreement, or in a credit facility agreement. + References No definition available. + Details
Name: | us-gaap_CashAvailableForDistributions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements payable within one year (or the operating cycle, if longer). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DeferredCompensationShareBasedArrangementsLiabilityCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Aggregate cash paid by the entity during the period to settle equity instruments granted under equity-based payment arrangements. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (k) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the liabilities, classified as other, for deferred compensation arrangements payable within one year or the operating cycle, if longer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 25 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 710 -SubTopic 10 -Section 30 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363 + Details
Name: | us-gaap_OtherDeferredCompensationArrangementsLiabilityCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(ii) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i) -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares issued under share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=bvs_BioVentusLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=bvs_EquityParticipationRightUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=bvs_BionessIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=bvs_ManagementIncentivePlanAndLiabilityClassifiedAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=bvs_EquityParticipationRightUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=bvs_BVLLCEmployeesTerminatedPriorToIPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=bvs_BVLLCEmployeesActiveAtIPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |